United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Pharma Industry News Are compounded weight-loss drugs the next opioid crisis? Inside the unregulated boom of off-label GLP-1s Are GLP-1 weight-loss drugs like semaglutide fueling a new safety crisis? Explore the unregulated boom in compounded injections and FDA’s crackdown. byPallavi MadhirajuSeptember 12, 2025